These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23738477)

  • 1. Challenging gene patents. Myriad ruling will impact personalized medicine.
    Lee J
    Mod Healthc; 2013 Apr; 43(15):8-9. PubMed ID: 23738477
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of gene patents and the implications for medicine.
    Sherkow JS; Greely HT
    JAMA Intern Med; 2013 Sep; 173(17):1569-70. PubMed ID: 23896757
    [No Abstract]   [Full Text] [Related]  

  • 3. 'The cost will drop'. Myriad Genetics' shares drop as competitors enter.
    Carlson J
    Mod Healthc; 2013 Jun; 43(24):12. PubMed ID: 23875233
    [No Abstract]   [Full Text] [Related]  

  • 4. [Human genes patents: yes or no? Reflections on the ruling of the Supreme Court of the United States].
    Lacadena JR
    Rev Derecho Genoma Hum; 2013; (38):167-81. PubMed ID: 24340831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myriad diversifies, fights rearguard action on patents.
    Allison M
    Nat Biotechnol; 2014 Mar; 32(3):211. PubMed ID: 24727763
    [No Abstract]   [Full Text] [Related]  

  • 6. Patents and laboratory medicine: what is required to turn an unpatentable natural phenomenon or law of nature into a patentable invention?
    Powlick JT
    Clin Chem; 2012 Aug; 58(8):1205-7. PubMed ID: 22504119
    [No Abstract]   [Full Text] [Related]  

  • 7. Supreme Court to decide whether payments by patent holders to delay production of generics are anticompetitive.
    Roehr B
    BMJ; 2012 Dec; 345():e8464. PubMed ID: 23236054
    [No Abstract]   [Full Text] [Related]  

  • 8. After the Myriad decision: do hurdles remain for diagnostics competition?
    Waller PR; Young DW
    MLO Med Lab Obs; 2013 Sep; 45(9):46. PubMed ID: 24147337
    [No Abstract]   [Full Text] [Related]  

  • 9. Patents. U.S. Supreme Court delves into what is and isn't patentable.
    Marshall E
    Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene patenting--is the pendulum swinging back?
    Kesselheim AS; Mello MM
    N Engl J Med; 2010 May; 362(20):1855-8. PubMed ID: 20375396
    [No Abstract]   [Full Text] [Related]  

  • 11. Invalidating human gene patenting: the U.S. Supreme Court rules in Association for Molecular Pathology v. Myriad Genetics.
    Kalyvas J; Little AS
    World Neurosurg; 2013 Dec; 80(6):680-1. PubMed ID: 24134909
    [No Abstract]   [Full Text] [Related]  

  • 12. US Supreme Court hears arguments in case of BRCA1 and BRCA2 [corrected] patents.
    McCarthy M
    BMJ; 2013 Apr; 346():f2446. PubMed ID: 23596230
    [No Abstract]   [Full Text] [Related]  

  • 13. US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes.
    Dyer C
    BMJ; 2012 Oct; 345():e6624. PubMed ID: 23033368
    [No Abstract]   [Full Text] [Related]  

  • 14. Supreme Court ruling broadens BRCA testing options.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Nov; 105(22):1671-2. PubMed ID: 24198329
    [No Abstract]   [Full Text] [Related]  

  • 15. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.
    Matthews KR; Cuchiara ML
    Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.
    Dyer C
    BMJ; 2012 Dec; 345():e8266. PubMed ID: 23223689
    [No Abstract]   [Full Text] [Related]  

  • 18. AMP v Myriad: the Supreme Court gives a win to personalized medicine.
    Klein RD
    J Mol Diagn; 2013 Nov; 15(6):731-2. PubMed ID: 24139185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
    Bouchard RA
    Health Law J; 2007; 15():247-94. PubMed ID: 19702185
    [No Abstract]   [Full Text] [Related]  

  • 20. Intellectual property. Supreme Court rules out patents on 'natural' genes.
    Marshall E
    Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.